FGF2 and acute myeloid leukemia: We found that the subset of CD34+ cells from AML subjects with highest expression of these HD proteins expressed the most Fgf2 and β3 integrin, and responded to treatment with Fgf-R or Syk inhibitors with decreased proliferation.